Meda
meda is a Munich-based German startup providing AI-powered clinical documentation and medical billing software for doctors and medical practices, automating patient notes, claims, and revenue cycle workflows.
- Company typePrivate
- Founded1954
- HeadquartersSolna, Sweden
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Meda does
meda is a recently launched German startup, headquartered in Munich, that builds AI-powered documentation and billing software for doctors and medical practices. The product integrates two workflows into a single platform: (1) automated clinical documentation, using natural language processing to generate and manage patient records, clinical notes, and medical forms from doctor input; and (2) automated billing, handling claims submission, payment processing, and revenue cycle management for medical practices. The two AI modalities disclosed are text (patient records, clinical notes, forms) and structured data (claims, invoices, financial records). The target customer segment is horizontal: individual doctors and medical practices that face administrative burden from documentation and billing complexity. Pricing is not publicly disclosed, no specific distribution or marketing channels are documented, and the company currently operates only in Germany within Western Europe. No funding rounds, headcount, revenue figures, customer logos, or management team information are disclosed in available sources, indicating an early pre-revenue or pre-traction stage as of the March 2026 reference date.
Note on data conflict: the firmographics block in the input also references "Meda AB," a Solna, Sweden-headquartered specialty pharmaceutical company founded in 1954 with 5,001–10,000 employees, including historical acquisitions of Rottapharm (2014), Acton Pharmaceuticals (2013), and Viatris (2005). These attributes describe a distinct, long-established pharma entity (which itself was later absorbed into Mylan/Viatris) and are not consistent with the operational data — AI documentation software, Munich headquarters, recent launch — that constitutes the bulk of the structured evidence. The analytical outputs above are grounded in the AI-startup operational data, which is more specific and more recent.
Meda firmographics
Firmographics- Name
- Meda
- Legal name
- Meda
- Website
- https://meda.se
- Company type
- Private
- Founded year
- 1954
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- meda is a Munich-based German startup providing AI-powered clinical documentation and medical billing software for doctors and medical practices, automating patient notes, claims, and revenue cycle workflows.
- Ownership category
- akta.pro rank
Where Meda is headquartered
LocationHeadquarters
- HQ city
- Solna
- HQ country
- Sweden
- HQ region
- Europe
Offices1 record
Markets served
Meda business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D
Meda product offering
Product offeringCore offering
Meda is an international specialty pharmaceutical company that develops, manufactures, and markets branded prescription pharmaceutical products across multiple therapeutic areas. Headquartered in Solna, Sweden since its 1954 founding, the company has expanded its portfolio and geographic footprint through strategic acquisitions including Rottapharm in 2014, Acton Pharmaceuticals in 2013, and Viatris in 2005.
Product overview
meda provides AI documentation and billing software designed specifically for doctors. The company's core product is an integrated AI-powered solution that combines automated medical documentation with billing software functionality, helping healthcare practitioners streamline their administrative workflows.
Differentiator
Problem solved
Functional benefit
Companies that use Meda
Customer profileSegments1 record
Ideal customer profiles1 record
Meda technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Meda partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights2 records
Meda competitors and assessment
Company assessmentBroad incumbents
- Shire (Takeda): Ireland-headquartered specialty pharmaceutical company (now part of Takeda) historically focused on rare diseases, neuroscience, and internal medicine. Comparable to Meda AB as a specialty pharma of similar acquisition-driven growth profile that ultimately consolidated into a larger player.
- Viatris: Global healthcare company formed through the merger of Mylan and Upjohn, and now the parent entity of Meda AB. Comparable as the broader incumbent that absorbed Meda's specialty portfolio, providing scale and global distribution that Meda operated within.
Direct peers
- Jazz Pharmaceuticals: Ireland-based specialty pharmaceutical company focused on CNS and oncology. Comparable to Meda AB in specialty pharma positioning, European corporate domicile, and acquisition-driven growth strategy.
- Endo International: Irish-domiciled specialty pharmaceutical company with franchises in branded specialty, generics, and sterile injectables. Comparable to Meda AB as a specialty pharma with overlapping product categories and similar size profile.
- Almirall: Spanish specialty pharmaceutical company focused on dermatology and specialty care across Europe. Closely comparable to Meda AB as a mid-cap European specialty pharma with overlapping therapeutic areas and similar commercial channels.
- H. Lundbeck: Danish specialty pharmaceutical company focused on brain diseases (CNS). Comparable to Meda AB as a Nordic-headquartered specialty pharma with similar scale and European geographic concentration.
- UCB: Belgian specialty pharmaceutical company focused on neurology and immunology. Comparable to Meda AB as a mid-cap European specialty pharma with similar product mix and distribution model.
- Ferring Pharmaceuticals: Swiss privately-held specialty pharmaceutical company with focus on reproductive health, gastroenterology, and urology. Comparable to Meda AB as a European privately-held specialty pharma of similar scale.
- Ipsen: French specialty pharmaceutical company with strong positions in oncology, neurology, and rare diseases. Comparable to Meda AB as a European-headquartered specialty pharma of similar scale.
- Recordati: Italian specialty pharmaceutical company operating across Europe with a focus on rare diseases and specialty care. Comparable to Meda AB in size, European geographic focus, and specialty pharma positioning.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Meda social profiles
Digital presenceMeda financial estimates
Financial estimateRevenue estimate
Valuation estimate
Meda leadership team
Management profileNumber of profiles
Profiles1 record
Meda funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Meda M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Meda
What does Meda do?
Meda is an international specialty pharmaceutical company that develops, manufactures, and markets branded prescription pharmaceutical products across multiple therapeutic areas. Headquartered in Solna, Sweden since its 1954 founding, the company has expanded its portfolio and geographic footprint through strategic acquisitions including Rottapharm in 2014, Acton Pharmaceuticals in 2013, and Viatris in 2005.
Is Meda a public or private company?
Meda is a private company. It is classified as unknown and is currently operating.
When was Meda founded?
Meda was founded in 1954. It employs 5,001 to 10,000 people.
Where is Meda based?
Meda is headquartered in Solna, Sweden, in the Europe region.
Who are Meda's main competitors?
Broad incumbents on record are Shire (Takeda) and Viatris. Direct peers are Jazz Pharmaceuticals, Endo International, Almirall, H. Lundbeck, UCB, Ferring Pharmaceuticals, Ipsen and Recordati.
Does Meda have an API?
No public API is recorded for Meda.